Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Jan 12;47(2):220–231. doi: 10.4093/dmj.2021.0327

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 Korean Diabetes Association

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Fig. 1. — All-cause (A, B, C) and cardiovascular (D, E, F) survival rates according to the presence of nonalcoholic fatty liver disease (NAFLD) or metabolic dysfunction-associated fatty liver disease (MAFLD). (A) All-cause survival: No NAFLD vs. NAFLD (P=0.200); (B) All-cause survival: No MAFLD vs. MAFLD (P<0.001); (C) All-cause survival: normal vs. NAFLD only vs. MAFLD only vs. both NAFLD and MAFLD (P<0.001); (D) Cardiovascular survival: No NAFLD vs. NAFLD (P=0.002); (E) Cardiovascular survival: No MAFLD vs. MAFLD (P<0.001); (F) Cardiovascular survival: normal vs. NAFLD only vs. MAFLD only vs. both NAFLD and MAFLD (P<0.001).